Comerica Bank’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.13K | Hold |
2,522
| – | – | ﹤0.01% | 3442 |
|
|
2025
Q1 | $2.98K | Hold |
2,522
| – | – | ﹤0.01% | 3408 |
|
|
2024
Q4 | $4.62K | Sell |
2,522
-813
| -24% | -$1.49K | ﹤0.01% | 3332 |
|
|
2024
Q3 | $5.67K | Buy |
3,335
+112
| +3% | +$190 | ﹤0.01% | 3298 |
|
|
2024
Q2 | $4.42K | Sell |
3,223
-1,172
| -27% | -$1.61K | ﹤0.01% | 3327 |
|
|
2024
Q1 | $16.5K | Sell |
4,395
-1,457
| -25% | -$5.46K | ﹤0.01% | 3081 |
|
|
2023
Q4 | $57.4K | Buy |
5,852
+402
| +7% | +$3.94K | ﹤0.01% | 2679 |
|
|
2023
Q3 | $45.5K | Buy |
+5,450
| New | +$45.5K | ﹤0.01% | 2735 |
|
|
2021
Q4 | – | Sell |
-124,020
| Closed | -$3.16M | – | 2185 |
|
|
2021
Q3 | $3.16M | Sell |
124,020
-8,580
| -6% | -$219K | 0.02% | 977 |
|
|
2021
Q2 | $3.42M | Buy |
132,600
+67,002
| +102% | +$1.73M | 0.02% | 954 |
|
|
2021
Q1 | $2.03M | Buy |
65,598
+59,766
| +1,025% | +$1.85M | 0.01% | 1343 |
|
|
2020
Q4 | $218K | Buy |
+5,832
| New | +$218K | ﹤0.01% | 2231 |
|